WILMINGTON, Mass., Aug. 5, 2014 /PRNewswire/ -- Implant
Sciences Corporation (OTCQB: IMSC), a high technology supplier of
systems and sensors for homeland security and defense markets,
today announced its CEO Glenn D.
Bolduc has been invited to attend the U.S.-Africa Business
Forum on Tuesday, August 5, 2014 in
Washington D.C. Mr. Bolduc is one
of a select group of U.S. CEOs invited to the event co-hosted by
the U.S. Department of Commerce and Bloomberg Philanthropies. Heads
of state will engage with business executives from both sides of
the Atlantic in conversations about successes and solutions to
build greater access for trade and investment in Africa. President Obama will participate in
the conversation with CEOs and government leaders from the U.S. and
Africa.
The first-ever U.S.-Africa Business Forum will be part of
President Obama's U.S.-Africa Leaders Summit, the first summit of
its kind, and the largest event that any U.S. president has ever
convened with African heads of state or government.
"I'm honored to be invited to this event on behalf of Implant
Sciences. Africa is a key export
market for our American-made explosives trace detectors and I look
forward to joining the conversation with African executives, heads
of state, and President Obama. Through our relationship with the
U.S. Department of Commerce, our established sales and distribution
network in Africa, and strong
record of customer satisfaction, we continue to drive sales in the
region. We appreciate the support we've received from the U.S.
Department of Commerce," Bolduc stated.
About Implant Sciences
Implant Sciences is a leader in developing and manufacturing
advanced detection capabilities to counter and eliminate the
ever-evolving threats from explosives and drugs. The Company's team
of dedicated trace detection experts has developed proprietary
technologies used in its commercial products, thousands of which
have been sold across more than 50 countries worldwide. Implant
Sciences is only the third manufacturer, and the sole
American-owned company, to currently have an ETD system named as a
Qualified Product by the US Transportation Security Administration.
The Company's ETDs have received approvals and certifications from
several international regulatory agencies including the TSA in the
U.S., STAC in France, the German
Ministry of the Interior, and the Ministry of Public Safety in
China. It also received a GSN 2013
Homeland Security Award for "Best Explosives Detection
Solution". All Implant Sciences products are recognized as
Qualified Anti-Terrorism Technologies by the Department of Homeland
Security. For further details on the Company and its products,
please visit the Company's website at www.implantsciences.com.
Safe Harbor Statement
This press release may contain certain "forward-looking
statements," as that term is defined in the Private Securities
Litigation Reform Act of 1995. Such statements are based on
management's current expectations and are subject to risks and
uncertainties that could cause the Company's actual results to
differ materially from the forward-looking statements. Such risks
and uncertainties include, but are not limited to, the risks that
our explosives detection products and technologies (including any
new products we may develop) may not be accepted by the
Transportation Security Administration or by other U.S. or foreign
government and law enforcement agencies or commercial consumers of
security products; economic, political and other risks associated
with international sales and operations could adversely affect our
sales; our business is subject to intense competition and rapid
technological change, and our success will depend on our ability to
develop and introduce new products; and other risks and
uncertainties described in our filings with the Securities and
Exchange Commission, including our most recent Forms 10-K, 10-Q and
8-K. Such statements are based on management's current expectations
and assumptions which could differ materially from the
forward-looking statements.
Contact:
Implant Sciences Corporation
Company Contact:
Glenn Bolduc, CEO
978-752-1700
or
Investor Contact:
Laurel Moody
646-810-0608
SOURCE Implant Sciences Corporation